Data / Form D filings / GLO Pharma, Inc.
GLO Pharma, Inc.: Form D filings
GLO Pharma, Inc., a biotechnology company in Carlsbad, CA, filed 7 Form D notices with the SEC between 2020 and 2023. The latest, on September 11, 2023, reports $53 million sold of a $53 million offering to 189 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2810 Caribou Court #130, Carlsbad, CA, 92010
- Phone
- (833) 456-7546
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1832546
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Amendment | $53,000,000 | $53,000,000 | 189 | Aug 30, 2021 | sec.gov | |
| Apr 3, 2023 | Amendment | $42,500,000 | $42,500,000 | 180 | Aug 30, 2021 | sec.gov | |
| Jun 13, 2022 | Amendment | $33,000,000 | $33,000,000 | 116 | Aug 30, 2021 | sec.gov | |
| Feb 4, 2022 | Amendment | $23,000,000 | $22,000,000 | $1,000,000 | 87 | Aug 30, 2021 | sec.gov |
| Sep 14, 2021 | New notice | $15,000,000 | $9,000,000 | $6,000,000 | 30 | Aug 30, 2021 | sec.gov |
| Nov 25, 2020 | New notice | $6,845,000 | $6,845,000 | 20 | Nov 13, 2020 | sec.gov | |
| Nov 25, 2020 | New notice | $511,000 | $511,000 | 22 | Nov 12, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dayna Quanbeck | Director | |
| Nicole Quinn | Director | |
| Marla Beck | Director | |
| Maureen Case | Director | |
| Fabian Seelbach | Director | |
| Douglas Wall | Director | |
| Lauren Otsuki | Director, Executive Officer | |
| Vimla Black-Gupta | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 11, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GLO Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.